These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9769372)

  • 1. In vitro cytotoxicity of paclitaxel-transferrin conjugate on H69 cells.
    Bicamumpaka C; Pagé M
    Oncol Rep; 1998; 5(6):1381-3. PubMed ID: 9769372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of transferrin-daunorubicin conjugates on small cell carcinoma of the lung (SCCL) cell line NCI-H69.
    Béjaoui N; Pagé M; Nöel C
    Anticancer Res; 1991; 11(6):2211-3. PubMed ID: 1663723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of multidrug-resistant MCF-7 cells to a transferrin-doxorubicin conjugate.
    Lemieux P; Pagé M
    Anticancer Res; 1994; 14(2A):397-403. PubMed ID: 8017839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel sensitization of multidrug-resistant cells to chemotherapy is independent of the cell cycle.
    Locke V; Davey R; Davey M
    Cytometry; 2001 Mar; 43(3):170-4. PubMed ID: 11170102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.
    Hennequin C; Giocanti N; Favaudon V
    Cancer Res; 1996 Apr; 56(8):1842-50. PubMed ID: 8620502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells.
    Sadava D; Phillips T; Lin C; Kane SE
    Cancer Lett; 2002 May; 179(2):151-6. PubMed ID: 11888669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells.
    Szwed M; Matusiak A; Laroche-Clary A; Robert J; Marszalek I; Jozwiak Z
    Toxicol In Vitro; 2014 Mar; 28(2):187-97. PubMed ID: 24055890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel cytotoxicity against human lung cancer cell lines increases with prolonged exposure durations.
    Georgiadis MS; Russell EK; Gazdar AF; Johnson BE
    Clin Cancer Res; 1997 Mar; 3(3):449-54. PubMed ID: 9815704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemosensitizing potential of GF120918 is independent of the magnitude of P-glycoprotein-mediated resistance to conventional chemotherapeutic agents in a small cell lung cancer line.
    Myer MS; Joone G; Chasen MR; van Rensburg CE
    Oncol Rep; 1999; 6(1):217-8. PubMed ID: 9864431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of [14C]-labelled and fluorescent-tagged paclitaxel derivatives as new biological probes.
    Rao CS; Chu JJ; Liu RS; Lai YK
    Bioorg Med Chem; 1998 Nov; 6(11):2193-204. PubMed ID: 9881110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
    Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J
    Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered Polymer-Transferrin Conjugates as Self-Assembling Targeted Drug Delivery Systems.
    Makwana H; Mastrotto F; Magnusson JP; Sleep D; Hay J; Nicholls KJ; Allen S; Alexander C
    Biomacromolecules; 2017 May; 18(5):1532-1543. PubMed ID: 28350442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of free and conjugated neocarzinostatin activity: studies on chromophore and protein uptake using a transferrin-neocarzinostatin conjugate.
    Schönlau F; Maibücher A; Köhnlein W; Garnett MC
    Z Naturforsch C J Biosci; 1997; 52(3-4):245-54. PubMed ID: 9167276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.
    Polizzi D; Pratesi G; Tortoreto M; Supino R; Riva A; Bombardelli E; Zunino F
    Cancer Res; 1999 Mar; 59(5):1036-40. PubMed ID: 10070960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
    Nag M; Gajbhiye V; Kesharwani P; Jain NK
    Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells.
    Wang F; Jiang X; Yang DC; Elliott RL; Head JF
    Anticancer Res; 2000; 20(2A):799-808. PubMed ID: 10810357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery.
    Miller ML; Roller EE; Zhao RY; Leece BA; Ab O; Baloglu E; Goldmacher VS; Chari RV
    J Med Chem; 2004 Sep; 47(20):4802-5. PubMed ID: 15369381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo cytotoxicity and antineoplastic activity of a transferrin-daunorubicin conjugate.
    Lemieux P; Pagé M; Noël C
    In Vivo; 1992; 6(6):621-7. PubMed ID: 1296812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species.
    Lin HL; Liu TY; Chau GY; Lui WY; Chi CW
    Cancer; 2000 Sep; 89(5):983-94. PubMed ID: 10964328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taxane sensitivity of ovarian carcinoma in vitro.
    Engblom P; Rantanen V; Kulmala J; Heiskanen J; Grenman S
    Anticancer Res; 1997; 17(4A):2475-9. PubMed ID: 9252666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.